Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03049449
Title T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

diffuse large B-cell lymphoma

gray zone lymphoma

angioimmunoblastic T-cell lymphoma

peripheral T-cell lymphoma

anaplastic large cell lymphoma

Hodgkin's lymphoma

mature T-cell and NK-cell lymphoma

primary mediastinal B-cell lymphoma

Therapies

ATLCAR.CD30 cells

Cyclophosphamide + Fludarabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.